NovoCure (NVCR) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026)
NovoCure (NVCR) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 5.69% |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn | -6.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.18% |
| Mar 31, 2026 | -4.17% |
| Dec 31, 2025 | -0.07% |
| Sep 30, 2025 | 9.18% |
| Jun 30, 2025 | 20.84% |
| Mar 31, 2025 | 35.10% |
| Dec 31, 2024 | 50.86% |
| Sep 30, 2024 | 60.77% |
| Jun 30, 2024 | 61.52% |
| Mar 31, 2024 | 61.62% |
| Dec 31, 2023 | 57.53% |
| Sep 30, 2023 | 53.18% |
| Jun 30, 2023 | 54.95% |
| Mar 31, 2023 | 45.40% |
| Dec 31, 2022 | 44.00% |
| Sep 30, 2022 | 154.25% |
| Jun 30, 2022 | 124.01% |
| Mar 31, 2022 | 113.69% |
| Dec 31, 2021 | 99.15% |
| Sep 30, 2021 | 13.90% |